2 7 5 ▁million . ▁ ▁In ▁May ▁ 2 0 1 4 ▁Boston ▁acquired ▁h yst eros cop ic ▁int ra uter ine ▁t issue ▁removal ▁special ist , ▁Io G yn , ▁Inc .. ▁In ▁September , ▁the ▁business ▁announced ▁it ▁would ▁ac quire ▁the ▁Inter vent ional ▁business ▁of ▁Bayer . ▁ ▁In ▁March ▁ 2 0 1 5 , ▁the ▁company ▁announced ▁it ▁would ▁ac quire ▁End o ▁International ▁Pl c ' s ▁American ▁Medical ▁Systems ▁u ro log y ▁business ▁for ▁at ▁least ▁$ 1 . 6 ▁billion , ▁expand ing ▁the ▁company ' s ▁health ▁and ▁pro state ▁treat ments . ▁In ▁April , ▁Boston ▁announced ▁its ▁intention ▁to ▁ac quire ▁X l um ena , ▁Inc .. ▁In ▁October ▁Boston ▁announced ▁it ▁had ▁inv ested ▁further ▁in ▁per cut aneous ▁mit ral ▁val ve ▁replacement ▁system ▁developer , ▁M Val ve ▁Techn ologies , ▁gain ing ▁a ▁right ▁to ▁ac quire ▁the ▁business ▁in ▁the ▁future . ▁ ▁In ▁July ▁ 2 0 1 6 ▁the ▁business ▁acquired ▁the ▁manufact urer ▁of ▁radio fre quency ▁ab lation ▁systems , ▁Cos man ▁Medical , ▁Inc .. ▁In ▁September , ▁Boston ▁announced ▁it ▁had ▁acquired ▁End o Choice ▁Hold ings , ▁Inc ., ▁becoming ▁part ▁of ▁the ▁Boston ▁Scient ific ▁End os copy ▁business ▁for ▁$ 8 . 0 0 ▁per ▁share ▁or ▁$ 2 1 0 ▁million ▁in ▁total . ▁In ▁November ▁the ▁company ▁acquired ▁the ▁gy ne col ogy ▁and ▁u ro log y ▁port folio